Cargando…
Statin Induced Regression of Cardiomyopathy Trial: A Randomized, Placebo-controlled Double-blind Trial
BACKGROUND: Hypertrophic cardiomyopathy (HCM), characterized by a thickened, fibrotic myocardium, remains the most common cause of sudden cardiac death in young adults. Based on animal and clinical data, we hypothesized that atorvastatin would induce left ventricular (LV) mass regression. METHODS: S...
Autores principales: | Hersi, Ahmad, Giannoccaro, J. Peter, Howarth, Andrew, Exner, Derek, Weeks, Sarah, Eitel, Ingo, Herman, R. Cameron, Duff, Henry, Ritchie, Debbie, Mcrae, Maureen, Sheldon, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363087/ https://www.ncbi.nlm.nih.gov/pubmed/28400935 http://dx.doi.org/10.4103/1995-705X.201784 |
Ejemplares similares
-
Statin tolerability: In defence of placebo-controlled trials
por: Tobert, Jonathan A, et al.
Publicado: (2015) -
Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Tilz, Roland R, et al.
Publicado: (2019) -
Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Tilz, Roland R, et al.
Publicado: (2019) -
Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
por: Howard, James P., et al.
Publicado: (2021) -
Phenotypic Analysis of Arrhythmogenic Cardiomyopathy in the Hutterite Population:
Role of Electrocardiogram in Identifying High‐Risk Desmocollin‐2
Carriers
por: Wong, Jorge A., et al.
Publicado: (2014)